Patents by Inventor John Charles Mayo

John Charles Mayo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimised subcutaneous therapeutic agents
    Patent number: 11351112
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: June 7, 2022
    Assignee: Cantab Biopharmaceuticals Patents Limited
    Inventors: William Henry, Richard Wolf-Garraway, John Charles Mayo, Michael James Earl
  • COLLOIDAL PARTICLES FOR USE IN MEDICINE
    Publication number: 20210093721
    Abstract: The invention provides a composition comprising a colloidal particle comprising about 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer for use in medicine, wherein said composition does not contain any pharmaceutically active agent.
    Type: Application
    Filed: May 26, 2020
    Publication date: April 1, 2021
    Inventors: William HENRY, Richard WOLF-GARRAWAY, John Charles MAYO
  • COLLOIDAL PARTICLES FOR USE IN MEDICINE
    Publication number: 20190192664
    Abstract: The invention provides a composition comprising a colloidal particle comprising about 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer for use in medicine, wherein said composition does not contain any pharmaceutically active agent.
    Type: Application
    Filed: October 14, 2016
    Publication date: June 27, 2019
    Inventors: William HENRY, Richard WOLF-GARRAWAY, John Charles MAYO
  • OPTIMISED SUBCUTANEOUS THERAPEUTIC AGENTS
    Publication number: 20180036229
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Application
    Filed: August 30, 2017
    Publication date: February 8, 2018
    Applicant: Cantab Biopharmaceuticals Patents Limited
    Inventors: William HENRY, Richard WOLF-GARRAWAY, John Charles MAYO, Michael James EARL
  • Formulations for the Treatment of Deep Tissue Pain
    Publication number: 20160175448
    Abstract: Disclosed herein are vesicular formulations comprising one or more phospholipids and one or more nonionic surfactants that are effective in the treatment of pain or inflammation or osteoarthritis, more specifically in the treatment of deep tissue pain, for example osteoarthritis and other joint or muscle pain, as well as methods of treating pain or inflammation or osteoarthritis, more specifically in the treatment of deep tissue pain, for example osteoarthritis and other joint or muscle pain using same.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 23, 2016
    Inventors: John Charles Mayo, George Langton Iliffe, Ulrich Vierl, Matthias Rother
  • OPTIMISED SUBCUTANEOUS THERAPEUTIC AGENTS
    Publication number: 20150086524
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Application
    Filed: April 16, 2013
    Publication date: March 26, 2015
    Applicant: CANTAB BIOPHARMACEUTICALS PATENTS LIMITED
    Inventors: William Henry, Richard Wolf-Garraway, John Charles Mayo, Michael James Earl
  • FORMULATIONS FOR THE TREATMENT OF DEEP TISSUE PAIN
    Publication number: 20120220669
    Abstract: Disclosed herein are vesicular formulations comprising one or more phospholipids and one or more nonionic surfactants that are effective in the treatment of pain or inflammation or osteoarthritis, more specifically in the treatment of deep tissue pain, for example osteoarthritis and other joint or muscle pain, as well as methods of treating pain or inflammation or osteoarthritis, more specifically in the treatment of deep tissue pain, for example osteoarthritis and other joint or muscle pain using same.
    Type: Application
    Filed: June 3, 2010
    Publication date: August 30, 2012
    Inventors: John Charles Mayo, George Langton Iliffe, Ulrich Vierl, Mattias Rother